Correlation Between Kulicke and Entheon Biomedical

Can any of the company-specific risk be diversified away by investing in both Kulicke and Entheon Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kulicke and Entheon Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kulicke and Soffa and Entheon Biomedical Corp, you can compare the effects of market volatilities on Kulicke and Entheon Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kulicke with a short position of Entheon Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kulicke and Entheon Biomedical.

Diversification Opportunities for Kulicke and Entheon Biomedical

0.48

Correlation Coefficient

Kulicke  Entheon Biomedical

Very weak diversification

The 3 months correlation between Kulicke and Entheon is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Kulicke and Soffa and Entheon Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entheon Biomedical Corp and Kulicke is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kulicke and Soffa are associated (or correlated) with Entheon Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entheon Biomedical Corp has no effect on the direction of Kulicke i.e., Kulicke and Entheon Biomedical go up and down completely randomly.

Pair Corralation between Kulicke and Entheon Biomedical

Given the investment horizon of 90 days Kulicke is expected to generate 61.59 times less return on investment than Entheon Biomedical. But when comparing it to its historical volatility, Kulicke and Soffa is 12.33 times less risky than Entheon Biomedical. It trades about 0.02 of its potential returns per unit of risk. Entheon Biomedical Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  17.00  in Entheon Biomedical Corp on September 26, 2024 and sell it today you would lose (5.00) from holding Entheon Biomedical Corp or give up 29.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Kulicke and Soffa  vs.  Entheon Biomedical Corp

Kulicke and Soffa

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Kulicke and Soffa are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak forward indicators, Kulicke may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Entheon Biomedical Corp

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Entheon Biomedical Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental drivers, Entheon Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Kulicke and Entheon Biomedical

The main advantage of trading using opposite Kulicke and Entheon Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kulicke position performs unexpectedly, Entheon Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entheon Biomedical will offset losses from the drop in Entheon Biomedical's long position.

The idea behind Kulicke and Soffa and Entheon Biomedical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.